DRUG
Bright Minds Biosciences
DRUG
DRUG
34 hedge funds and large institutions have $188M invested in Bright Minds Biosciences in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
7% more capital invested
Capital invested by funds: $176M → $188M (+$12M)
6.43% less ownership
Funds ownership: 80.54% → 74.11% (-6.4%)
Holders
34
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$21.8M | |
| 2 | +$5.49M | |
| 3 | +$2.43M | |
| 4 |
SCM
Sio Capital Management
New York
|
+$2.01M |
| 5 |
PA
Perceptive Advisors
New York
|
+$1.48M |
Top Sellers
| 1 | -$9.18M | |
| 2 | -$8.82M | |
| 3 | -$3.13M | |
| 4 |
SFAM
Springhill Fund Asset Management
Hong Kong
|
-$2.18M |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$917K |
